Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.
Los Angeles Times; Monday May 12, 1997 Page B-4
In January, federal drug czar Barry McCaffrey declared that doctors who recommend the medical use of marijuana could face federal prosecution and the revocation of their right to prescribe federally monitored drugs. That threat smacked of the "gag rules" against doctors that the government so deplores in managed care contracts. Three months later, federal Drug Enforcement Agency agents staged their first raid on one of California's medical marijuana buyers' clubs since Proposition 215's passage.
U.S. District Judge Fern Smith struck a blow for good sense a couple of weeks ago, issuing an order that both blocks federal retaliation against physicians and tightens the circumstances for recommending marijuana. Rather than sanctioning Proposition 215's original, sloppy wording--which allows physicians and other medical providers to recommend marijuana for nearly whatever they please--Smith ruled that her court's protection applied only to four serious medical conditions: AIDS or HIV infection, cancer, glaucoma and seizures or muscle spasms associated with certain debilitating conditions.
Smith's ruling is only a temporary solution, for the DEA still regards marijuana as a Schedule 1 drug, in a class with heroin, meaning it's an illegal substance lacking any medical value. A permanent solution would be for the federal government to reclassify marijuana under Schedule 2, a carefully monitored category of risky and often addictive substances like morphine that have some medical utility and can be legally prescribed by doctors.
This has recently been urged by arbiters of mainstream medical opinion like the New England Journal of Medicine and might forestall other states that are considering their own marijuana propositions. To put more light and less heat on the subject, the Clinton administration should also support careful studies of which chemicals in marijuana ease or exacerbate which disorders and why.
Guidelines from the National Institutes of Health on promising directions for such research are expected later this month. Congress and the administration should ensure that marijuana studies go briskly forward.
Copyright 1997/The Times Mirror Company. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Permissions Desk, The Los Angeles Times, Times Mirror Square, Los Angeles, CA 90053.
970512
LT970508
Copyright © 1997 - Los Angeles Times. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Los Angeles Times, Permissions, Times Mirror Square, Los Angeles, CA 90053. http://www.latimes.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .